[go: up one dir, main page]

HK1169398A - Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide - Google Patents

Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide Download PDF

Info

Publication number
HK1169398A
HK1169398A HK12110091.3A HK12110091A HK1169398A HK 1169398 A HK1169398 A HK 1169398A HK 12110091 A HK12110091 A HK 12110091A HK 1169398 A HK1169398 A HK 1169398A
Authority
HK
Hong Kong
Prior art keywords
oxy
ylpropyl
dicarboxamide
methyloxy
quinolin
Prior art date
Application number
HK12110091.3A
Other languages
Chinese (zh)
Inventor
Hilary Cannon
David Igo
Tri Tran
Original Assignee
Exelixis, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exelixis, Inc. filed Critical Exelixis, Inc.
Publication of HK1169398A publication Critical patent/HK1169398A/en

Links

HK12110091.3A 2009-07-17 2010-07-16 Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide HK1169398A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US61/226,509 2009-07-17

Publications (1)

Publication Number Publication Date
HK1169398A true HK1169398A (en) 2013-01-25

Family

ID=

Similar Documents

Publication Publication Date Title
IL217537A0 (en) Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide
ZA201206679B (en) Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
ZA201105167B (en) Malate salt of n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide,and crystalline forms thereof for the treatment of cancer
IL231495B (en) N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide compounds or a pharmaceutically acceptable salt thereof in the preparation of a medicament for the treatment of osteoporosis
ZA201605424B (en) Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use
MX2013005826A (en) Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture.
EP2387561A4 (en) Improved process for the preparation of highly pure (3r,5s)-7-ý2-cyclopropyl-4-(4-fluorophenyl) quinolin-3-yl¨-3,5-dihydroxy-6(e)-heptenoic acid and pharmaceutically acceptable salts thereof
WO2012071509A3 (en) Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
PL2684877T3 (en) Pharmaceutically acceptable salt of (e)-n-[4-[[3-chloro-4-(2-pyridylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolyl]-3-[(2r)-1-methylpyrrolidin-2-yl]prop-2-enamide, preparation method therefor, and medical use thereof
BR112013015859A2 (en) compound, use of a compound, methods of prevention, treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications, and, pharmaceutical composition
FR2960875B1 (en) HEXAFLUOROISOPROPYL CARBAMATE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
WO2013098833A3 (en) Processes and intermediates for preparing rivaroxaban
IL230487B (en) 6-(n-(7-chloro-1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5- yl)methylsulfonamido)-5-cyclopropyl-2-(4-fluorophenyl)-n-methylbenzofuran-3-carboxamide compounds, pharmaceutically acceptable salts thereof and pharmaceutical composition comprising them
PT2517700E (en) Pharmaceutically acceptable cocrystals of n-[2-(7-methoxy-1-naphthyl]acetamide and methods of their preparation
WO2014041565A3 (en) Improved process for preparation of vilanterol and intermediates thereof
WO2011089126A3 (en) Novel retigabine composition
BR112013015877A2 (en) compound, use of a compound, prevention methods. treatment, amelioration or prophylaxis of physiological disorders or diseases, and treatment or amelioration of cosmetic indications, and, pharmaceutical composition.
HRP20171742T1 (en) 2,4,6-TRIFLUOR-N- [6- (1-METHYLPIPERIDINE-4-CARBONYL) PYRIDIN-2-IL] BENZAMIDE, INTENDED FOR THE TREATMENT OF MIGRENE ORAL OR INTRAVENIC
IL225557A (en) Method for the preparation of (3s,3s') 4,4'-disulfanediylbis (3-aminobutane 1-sulfonic acid)
IT1405996B1 (en) PROCEDURE FOR THE PREPARATION OF 2,5-DIAMINOTOLUOL
HK1169398A (en) Crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1, 1-dicarboxamide
HK1181039A (en) Hydrated crystalline forms of n-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
WO2010142143A9 (en) Pirfenidone compound, preparation method and use thereof
WO2011112689A3 (en) Salts of an indazolylpyrrolotriazine
PL392177A1 (en) New S-(+)-(5,5-dimethylcyclohex-2-en-1-yl) acetaldehyde and the process for preparation thereof